Market Tracker

12/02 5:16pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

0.8708
Delayed Data
As of Dec 02
 +0.0108 / +1.26%
Today’s Change
0.49
Today|||52-Week Range
3.05
-46.90%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close0.86
Today’s open0.87
Day’s range0.85 - 0.89
Volume66,142
Average volume (3 months)571,312
Market cap$25.3M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)+4.17%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc+0.05+3.45%
APPYVenaxis Inc-0.35-7.95%
BMRABiomerica Inc-0.10-4.52%
APHBAmpliPhi Biosciences...-0.02-4.06%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts